The Effect of CTAB Concentration in Cationic PLG Microparticles on DNA Adsorption and in Vivo Performance

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Pharmaceutical Research

• Publication date

  2003-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1023/A:1022327305369PMID 12636163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Technological advances to increase immunogenicity of DNA vaccines

  2002cited by this paper
• Therapeutic ultrasound: Its application in drug delivery

  2002cited by this paper
• Immunoinhibitory DNA Vaccine Protects Against Autoimmune Diabetes Through cDNA Encoding a Selective CTLA-4 (CD152) Ligand

  2002cited by this paper
• The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery

  2001cited by this paper
• Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

  2001cited by this paper
• DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines1

  2001cited by this paper
• Cationic microparticles: A potent delivery system for DNA vaccines.

  2000cited by this paper
• Enhancement of DNA vaccine potency by electroporation in vivo.

  2000cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cited by this paper
• Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

  2000cited by this paper
• Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.

  2000cited by this paper
• Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

  2000cited by this paper
• Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene

  2000cited by this paper
• PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization.

  1999cited by this paper
• Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

  1999cited by this paper
• Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

  1999cited by this paper
• Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA

  1999cited by this paper
• Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

  1998cited by this paper
• DNA vaccines.

  1997cited by this paper
• Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid).

  1997cited by this paper
• Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

  1997cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993influential reference

• Emerging Cationic Nanovaccines

  2024cites this paper
• Polymer‐Based mRNA Delivery Strategies for Advanced Therapies

  2023cites this paper
• Improving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension

  2020cites this paper
• Aluminosilicate-based composites functionalized with cationic materials: possibilities for drug-delivery applications

  2019cites this paper
• Preparation and Characterization of PLGA Nanoparticles Containing Plasmid DNA Encoding Human IFN-lambda-1/IL-29

  2019cites this paper
• Toll like receptors and cytokines as immunostimulatory adjuvants in poultry vaccines: current status and future trends

  2019cites this paper
• Microparticles for Vaccine Delivery

  2017cites this paper
• Comparative assessment of poly ( D , L-lactide-co-glycolide ) nanoparticles modified by either cetyltrimethylammonium bromide or chitosan for plasmid DNA adsorption

  2017cites this paper
• Chitosan-functionalized poly(lactide-co-glycolide) nanoparticles: breaking through the brain’s tight security gateway

  2016cites this paper
• The Current Research Status of PLGA as Drug and Gene Carrier

  2016cites this paper
• Polymer Particulates in Drug Delivery.

  2016cites this paper
• Recent progress concerning CpG DNA and its use as a vaccine adjuvant

  2014cites this paper
• Photodynamic inactivation of chlorin e6‐loaded CTAB‐liposomes against Candida albicans

  2013cites this paper
• Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines

  2013cites this paper
• A Colorimetric Aptamer Biosensor Based on Gold Nanoparticles for the Ultrasensitive and Specific Detection of Tetracycline in Milk

  2013cites this paper
• Hydrolytic cationic ester microparticles for highly efficient DNA vaccine delivery.

  2013cites this paper
• Non-Viral Delivery Systems in Gene Therapy

  2013cites this paper
• Chapter 1 Non-Viral Delivery Systems in Gene Therapy

  2013cites this paper
• Formulation and characterisation of PLGA microspheres as vaccine adjuvants

  2013cites this paper
• Zwitterionic Polymers and Their Derivatives as Drug and Gene Delivery Carriers and Implantable Materials

  2012cites this paper
• Improving Polymer-Mediated DNA Vaccine Delivery

  2011cites this paper
• Delivery to Intracellular Targets by Nanosized Particles

  2011cites this paper
• Chitosan-surface modified poly(lactide-co-glycolide) nanoparticles as an effective drug delivery system

  2011cites this paper
• Preparation and in vitro characterisation of Ehrlichia ruminantium plasmid DNA and proteins encapsulated into and DNA adsorbed onto biodegradable microparticles.

  2010cites this paper
• A study of some lipid-based drug delivery systems

  2010cites this paper
• Biodegradable microparticles as a single dose delivery system for Ehrlichia ruminantium vaccines

  2010cites this paper
• Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.

  2010cites this paper
• Toward advanced modular drug and gene delivery system

  2010cites this paper
• Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.

  2010cites this paper
• Innovative strategies for co-delivering antigens and CpG oligonucleotides.

  2009cites this paper
• THEMED SECTION: VECTOR DESIGN AND DRUG DELIVERY REVIEW Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009cites this paper
• Preparation, characterization, and in vitro cytotoxicity study of cationic PCL-pluronic-PCL (PCFC) nanoparticles for gene delivery.

  2009cites this paper
• Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices.

  2009cites this paper
• Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009cites this paper
• Polymeric Nano- and Microparticles for the Delivery of Antisense Oligonucleotides and siRNA

  2008cites this paper
• Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery.

  2008cites this paper
• State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.

  2008cites this paper
• One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery.

  2008cites this paper
• High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine.

  2008cites this paper
• One-step preparation of poly(ϵ-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery

  2008cites this paper
• Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods

  2008influential citation
• Charge Modification of Pharmaceutical Nanocarriers: Biological Implications

  2008cites this paper
• Rationally Designed Synthetic Vectors for Gene Delivery

  2007cites this paper
• Pulmonary vaccine delivery

  2007cites this paper
• Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.

  2007cites this paper
• Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

  2007cites this paper
• Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.

  2007cites this paper
• Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV.

  2006cites this paper
• Novel approaches to pediatric vaccine delivery.

  2006cites this paper
• Microparticles as vaccine delivery systems

  2006cites this paper
• Microparticle-based technologies for vaccines.

  2006cites this paper
• Pulmonary DNA vaccination: Concepts, possibilities and perspectives

  2005cites this paper
• Polymeric microspheres as stabilizing anchors for oligonucleotide delivery to dendritic cells.

  2005cites this paper
• Novel Approaches to Vaccine Delivery

  2004cites this paper
• PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium

  2004cites this paper
• Developing and Testing of Drug Carrier Systems for Pulmonary Drug Delivery

  2004cites this paper
• Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein.

  2004cites this paper
• Microparticles for the delivery of DNA vaccines

  2004cites this paper
• Cationic Microparticles and Emulsions As Effective Delivery Systems for Immune Stimulatory CpG DNA

  2004cites this paper